GRP
MBX

Global Retirement Partners’s MBX Biosciences MBX Stock Holding History

Global Retirement Partners’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$599 Buy
+19
New +$461 ﹤0.01% 3967

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Global Retirement Partners's MBX Position: Q4 2025 in Review

Global Retirement Partners opened a new position in MBX Biosciences (MBX) in Q4 2025: 19 shares worth $599. The stake represents ﹤0.01% of the portfolio and ranks #3967 among its holdings.

138 funds tracked by Wall St. Rank hold MBX as of Q4 2025.

  • Global Retirement Partners held 19 shares of MBX Biosciences worth $599 as of Q4 2025.
  • MBX Biosciences was a new Global Retirement Partners position in Q4 2025.
  • MBX Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3967 holding.
  • 138 funds tracked by Wall St. Rank held MBX Biosciences as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.